1. Anti-EGFR-Based Therapy in Recurrent or Metastatic HNSCC – What Difference Does it Make?. (2nd January 2023) Authors: Eggers, Hendrik; Häbel, Lea; Ganser, Arnold; Grünwald, Viktor; Merten, Roland; Warnecke, Athanasia; Durisin, Martin; Ivanyi, Philipp Journal: Cancer investigation Issue: Volume 41:Number 1(2023) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer. (April 2011) Authors: Waalkes, Sandra; Eggers, Hendrik; Blasig, Hanna; Atschekzei, Faranaz; Kramer, Mario W; Hennenlotter, Jöörg; Träänkenschuh, Wolfgang; Stenzl, Arnulf; Serth, Jüürgen; Schrader, Andres J; Kuczyk, Markus A; Merseburger, Axel S Journal: Biomarkers in medicine Issue: Volume 5:Number 2(2011) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FLA‐IDA salvage chemotherapy combined with a seven‐day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia. (4th November 2019) Authors: Shahswar, Rabia; Beutel, Gernot; Klement, Piroska; Rehberg, Alina; Gabdoulline, Razif; Koenecke, Christian; Markel, Dominik; Eggers, Hendrik; Eder, Matthias; Stadler, Michael; Hambach, Lothar; Ehrlich, Steve; Göhring, Gudrun; Schlegelberger, Brigitte; Dammann, Elke; Reuter, Marlene; Wichmann, Mar... Journal: British journal of haematology Issue: Volume 188:Number 3(2020) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗